Tumor-cell FAP promoted invasion and independently predicted significantly poorer recurrence-free survival (RFS), even in early-stage disease (multivariable Cox p = 0.022 for pT1-2), surpassing established biomarkers such as PD-L1 in capturing aggressive biological features. This evidence concerns the gene FAP and neoplasm.